How Classification Of Cell And Gene Therapies As Drugs, Devices Or Procedures Could Have Significant Implications

October 4, 2018 Danielle Twigg

Educational poster presented at ISPOR Meeting, Barcelona, November 2018

Previous Article
Making Sense From Anti-Sense: Lessons In Translating Expedited Regulatory Approval Into Reimbursement And Commercial Success
Making Sense From Anti-Sense: Lessons In Translating Expedited Regulatory Approval Into Reimbursement And Commercial Success

Next Article
Has The Nice HST Process Been A Success? Comparison With Other European HTA Bodies
Has The Nice HST Process Been A Success? Comparison With Other European HTA Bodies